Epitalon and MOTS-c are both studied under the longevity banner, but they act on entirely different aging mechanisms — telomere maintenance versus mitochondrial energy metabolism.
Research reference only. Not medical advice, prescribing guidance, or a product recommendation.
| Dimension | Epitalon | MOTS-c |
|---|---|---|
| Structure | Tetrapeptide (AEDG), pineal-derived | Mitochondrial-derived peptide (16 aa) |
| Primary mechanism | Telomerase upregulation → telomere length | Mitochondrial / AMPK metabolic regulation |
| Longevity rationale | Replicative lifespan, circadian / pineal axis | Metabolic healthspan, exercise mimetic |
| Originating research | Khavinson group (St. Petersburg) | Mitochondrial-derived-peptide field (USC / Cohen lab) |
| Evidence stage | Preclinical / early; limited Western RCTs | Preclinical (largely rodent / cell) |
| Status | Research compound | Research compound |
Epitalon (AEDG), a pineal-derived tetrapeptide developed by Khavinson’s group, is studied for upregulating the telomerase catalytic subunit and extending telomere length — one study extended human fibroblast replicative lifespan beyond the Hayflick limit without malignant transformation. Its longevity rationale is telomere maintenance and the pineal / circadian axis.
MOTS-c is a mitochondrial-derived peptide studied for metabolic regulation — activating AMPK and acting as an exercise-mimetic signal that improves insulin sensitivity and metabolic flexibility in models. So the two address aging from opposite ends: Epitalon at the replicative / telomere level, MOTS-c at the mitochondrial / metabolic level.
These are not substitutes — they target different aging mechanisms. Epitalon’s draw is telomere maintenance (with the caveat that its evidence is concentrated in a single research tradition and lacks large Western RCTs); MOTS-c’s is mitochondrial / metabolic regulation (largely preclinical). Both are research compounds, neither is FDA-approved. This page is a research and educational reference.
Epitalon (AEDG) is a pineal-derived tetrapeptide studied for telomerase upregulation and telomere length. MOTS-c is a mitochondrial-derived peptide studied for metabolic regulation via AMPK as an exercise-mimetic signal. They target different aging mechanisms.
Epitalon’s research is concentrated in the Khavinson tradition with limited independent Western RCTs; MOTS-c data is largely preclinical (rodent and cell). Both should be read as early-stage.
Because they act on different mechanisms — telomere maintenance versus mitochondrial metabolism — they are studied as complementary longevity approaches rather than alternatives.
No. Both are research compounds and not FDA-approved. This page is a research and educational reference, not medical advice.